HIV/AIDS Therapy
Findings from University Hospital provide new insights into HIV/AIDS therapy
Published in AIDS Weekly, July 23rd, 2007
A new study, "Human herpesvirus 6-associated retrobulbar optic neuritis in an HIV-infected patient: response to anti-herpesvirus therapy and long-term outcome," is now available. According to a study from France, "Like other herpesviruses, human herpesvirus 6 (HHV-6) can reactivate in immunocompromised patients. A case is described of an HIV-1-infected patient who developed bilateral retrobulbar optic neuritis associated with HHV-6 infection."
"A 59-year-old woman, infected with HIV for 18 years, interrupted antiretroviral treatment because of therapeutic failure and severe metabolic complications. She presented subsequently with blurred vision and ophthalmological...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-07-23)
More Articles from AIDS Weekly
- HIV/AIDS
A compound from olive-pomace oil gets 80 percent slowing down of HIV spread - HIV/AIDS
Japan's DNAVEC and IAVI partner on novel AIDS vaccine strategy - HIV/AIDS
Safety of new microbicide for HIV prevention to be tested in young women in US trial - HIV/AIDS
Scaling up HIV prevention programs is cost effective - HIV/AIDS
Self-Monitoring Reduces High-Risk Behavior Among HIV+ - HIV/AIDS Cancer
Kaposi sarcoma arises independently from multiple cells - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
